Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02011126
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more
Children's Oncology Group
Not applicableUnknownNCT02526043
What this trial is testing

Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 180
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Not applicableNot Yet RecruitingNCT07368049
What this trial is testing

MR 7700 Multinuclear Application Clinical Study

Who this might be right for
Hepatocellular CarcinomaMRI
Philips Clinical & Medical Affairs Global 100
Testing effectiveness (Phase 2)Study completedNCT00083785
What this trial is testing

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal NeoplasmsLiver Neoplasms+1 more
Light Sciences LLC 25
Testing effectiveness (Phase 2)Study completedNCT00819650
What this trial is testing

A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 200
Not applicableStudy completedNCT05643391
What this trial is testing

Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Erasme University Hospital 20
Not applicableUnknownNCT03088150
What this trial is testing

COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation

Who this might be right for
ColoRectal CancerLiver Metastasis Colon CancerLiver Metastases+1 more
Amsterdam UMC, location VUmc 618
Not applicableEnded earlyNCT00455091
What this trial is testing

A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Health Research Institutes, Taiwan 117
Large-scale testing (Phase 3)UnknownNCT00728078
What this trial is testing

Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 200
Not applicableStudy completedNCT01631318
What this trial is testing

Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases

Who this might be right for
Liver MetastasesColon Cancer
Stanford University 34
Not applicableStudy completedNCT03534843
What this trial is testing

A Comparison Between Child-Pugh and Albumin-Bilirubin Scores

Who this might be right for
Rupture, SpontaneousRupture LiverHepatocellular Carcinoma+1 more
Huazhong University of Science and Technology 230
Testing effectiveness (Phase 2)Looking for participantsNCT06860815
What this trial is testing

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Carcinoma in the Liver
City of Hope Medical Center 11
Early research (Phase 1)Looking for participantsNCT06204835
What this trial is testing

ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery

Who this might be right for
Hepatocellular Carcinoma
Institute of Automation, Chinese Academy of Sciences 90
Not applicableActive Not RecruitingNCT04258813
What this trial is testing

Onco-primary Care Networking to Support TEAM-based Care

Who this might be right for
Blood PressureHypertensionCancer+15 more
Duke University 313
Not applicableUnknownNCT04443049
What this trial is testing

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Institute of Liver and Biliary Sciences, India 170
Testing effectiveness (Phase 2)UnknownNCT03732547
What this trial is testing

Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Not applicableUnknownNCT06325826
What this trial is testing

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Who this might be right for
Hepatocellular Carcinoma
Egyptian Liver Hospital 500
Not applicableNot Yet RecruitingNCT07584317
What this trial is testing

AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)

Who this might be right for
Hepatocellular Carcinoma
Gao-jun Teng 1,170
Not applicableNot Yet RecruitingNCT06708650
What this trial is testing

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPD-1 Inhibitors
Guiping People's Hospital 50
Next Page